Evidence map›Paper›PMID 32606160›Full record

ArticleIn vivo (Athens, Greece)

The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer.

Shozo Mori, Taku Aoki, Kazuma Tago, Takayuki Shimizu, Nobuhiro Harada, Kyung-Hwa Park, Yuhki Sakuraoka, Takayuki Shiraki, Yukihiro Iso, Keiichi Kubota

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Differential expression ofJournal of Taibah University Medical Sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shozo MoriDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan s-mori@dokkyomed.ac.jp.
Taku AokiDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Kazuma TagoDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Takayuki ShimizuDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Nobuhiro HaradaDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Kyung-Hwa ParkDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Yuhki SakuraokaDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Takayuki ShirakiDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Yukihiro IsoDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Keiichi KubotaDepartment of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
Dokkyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimAlthough ABO blood group has been reported to be associated with the outcome of patients with pancreatic cancer, little is known about its impact on patients with biliary tract cancer (BTC). We evaluated the prognostic relevance of ABO blood group in patients who had undergone resection of BTC. PATIENTS AND

methodsA total of 154 patients with BTC undergoing pancreatoduodenectomy were retrospectively reviewed. Associations between ABO blood group and patient survival were evaluated by univariate and multivariate analysis.

resultsThe 5-year overall survival rate was higher in group O patients (n=46) than in other blood group patients (n=108) (65.8% vs. 47%, p=0.005). Multivariate analysis revealed that a non-O blood group was an independent risk factor for poor survival (p=0.021).

conclusionABO blood group is associated with the prognosis of patients with resected BTC; group O patients have a better outcome.

Indexed as

ABO Blood-Group SystemBiliary Tract NeoplasmsHumansPancreaticoduodenectomyPrognosisRetrospective StudiesABO Blood-Group SystemABO blood groupbiliary tract cancerpancreatoduodenectomyprognosis

Identifiers

PMID32606160
PMCPMC7439892
OpenAlexW3038443000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.